Challenges and lessons learned in Neonatal Drug Therapies

Drugs are extensively used in the newborns and some of these pharmacologic agents are key elements contributing to the improved outcomes and survival of the sick neonates. This issue of the Seminars in Perinatology focuses on the more vexing and promising pharmacologic agents being used and may be potentially used in the newborn. Drugs are molecular entities that elicit a physiologic, biochemical, or molecular response. It is clear that stem cell-based therapies are potent pharmacologic strategies that represent the next breakthrough for neonatal morbidities such as bronchopulmonary dysplasia, periventricular leucomalacia and hypoxic ischemic encephalopathy where perinatal insults may compromise progenitor cells leading to the arrest in normal lung and neuronal growth and development.

Source: Seminars in Perinatology - January 11, 2016 Category: Perinatology & Neonatology Authors: Jacob V. Aranda Source Type: research